news
METIS meets primary endpoint
The phase 3 METIS clinical trial demonstrated a statistically significant improvement in time to intracranial progression for patients treated with Tumor Treating Fields therapy and supportive care compared to supportive care alone in the treatment of patients with brain metastases from non-small cell lung cancer following stereotactic radiosurgery.
learn moreJennifer continues to train in karate while facing glioblastoma. We are inspired by her resolve. Thanks, @6abc, for sharing this story!
#patientforward #GBM #btsm #TTFields
We are proud to share that the results of the METIS phase 3 clinical trial in brain metastases from non-small cell lung cancer will be presented at the @ASCO Annual Meeting. Learn more: https://www.novocure.com/Results-of-Novocures-METIS-Phase-3-Clinical-Trial-for-Patients-with-Brain-Metastasis-from-Non-Small-Cell-Lung-Cancer-to-be-Presented-as-Late-Breaking-Abstract-at-ASCO-2024/ #brainmetastases #lungcancer #clinicaltrials
Grace Zaugg couldn’t wait to join her softball team on the field after her hip surgery. And her mom, Shelly? She won’t even think about letting a brain tumor get in the way of cheering her daughter on. We are inspired by this mom and daughter!
Frank Leonard, President of Novocure Oncology, is on the new episode of the Rare Enough podcast hosted by DJ Stewart, @HeadfortheCure community outreach coordinator. https://headforthecure.org/rare-enough-podcast/ #oncology #leadership #patientforward #WeAreNovocure
Our team had a great week at #AACR24 in San Diego, where we shared some of the latest scientific research on Tumor Treating Fields (#TTFields) therapy.
Learn more about us: http://novocure.com
#oncology #innovation #WeAreNovocure #patientforward
Meet Leonardo Lustgarten, Medical Director and Lead, Neurosurgery and Neuro-Oncology. He's in San Diego for the @AACR Annual Meeting.
Stop by Booth 719 or visit us online to learn more about our therapy. http://tumortreatingfieldstherapy.com
#WeAreNovocure #TTFields #AACR24 #oncology